Research Progress on Postoperative Minimal/Molecular Residual Disease Detection in Lung Cancer

Lung cancer is the leading cause of cancer‐related deaths worldwide. Approximately 10%–50% of patients experience relapse after radical surgery, which may be attributed to the persistence of minimal/molecular residual disease (MRD). Circulating tumor DNA (ctDNA), a common liquid biopsy approach, has...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Manqi, Shen, Haifeng, Wang, Ziyang, Kanu, Nnennaya, Chen, Kezhong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9215711/
https://www.ncbi.nlm.nih.gov/pubmed/35774426
http://dx.doi.org/10.1002/cdt3.10

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9215711/
https://www.ncbi.nlm.nih.gov/pubmed/35774426
http://dx.doi.org/10.1002/cdt3.10

Ejemplares similares